Kaynak Cagdas, Aslan Muzaffer
Cardiology, Siirt Education Research Hospital, Siirt, TUR.
Cureus. 2021 Feb 12;13(2):e13318. doi: 10.7759/cureus.13318.
Ticagrelor is a potent P2Y12 inhibitor that is increasingly used in acute coronary syndrome. Although drug-related intrahepatic hemorrhages have been reported with anticoagulant drugs, no case of intrahepatic hemorrhage due to ticagrelor has been encountered in the literature. With this case, we tried to explain that potent antiaggregant drugs may cause this rare bleeding complication. Although ticagrelor is used for rapid antiaggregation effect in acute coronary syndrome, de-escalation to clopidogrel treatment in elderly patients during the hospitalization period is a more reasonable option.
替格瑞洛是一种强效P2Y12抑制剂,在急性冠脉综合征中使用越来越广泛。虽然已有抗凝药物导致药物相关性肝内出血的报道,但文献中尚未有替格瑞洛引起肝内出血的病例。通过本病例,我们试图说明强效抗血小板药物可能会导致这种罕见的出血并发症。尽管替格瑞洛用于急性冠脉综合征的快速抗血小板作用,但老年患者在住院期间降级为氯吡格雷治疗是更合理的选择。